Clearance with the left side of the SMV as the medial boundary
ProcedureUndergo radical resection for right colon cancer with the left side of the SMV as the medial boundary
NCT Number: NCT06986538
This is a prospective multicenter randomized controlled clinical study to explore the extent of lymph node dissection in progressive right hemicolon cancer and to elucidate the pattern of lymphatic drainage in the right hemicolon.
Trial opening soon.
Get Notified18 year–75 year
All sexes
Interventional
Not applicable
Cancer Hospital, Chinese Academyof Medical Sciences, Beijing, Beijing Municipality, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Undergo radical resection for right colon cancer with the left side of the SMV as the medial boundary
Undergo radical resection for right colon cancer with the left side of the SMA as the medial boundary
Time frame: The third postoperative year
It is defined as the proportion of patients from the start of randomization to the end of the third year without any of the following events: disease progression, local recurrence, distant metastasis, second primary colorectal cancer, or death from any cause.
Time frame: The third postoperative year
The time from randomization to death from any cause.
Contact information is provided by the study sponsor or research team.
Dechang Diao
CONTACT
Jiaqi Ren
CONTACT
Sixth Affiliated Hospital, Sun Yat-sen University
Other
A Multicenter Randomized Controlled Study of the Extent of Lymph Node Dissection for Advanced Right-sided Colon Cancer
Acronym: MARCH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.